Page last updated: 2024-11-07

cericlamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cericlamine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131074
CHEMBL ID2106462
SCHEMBL ID114233
MeSH IDM0180165

Synonyms (14)

Synonym
cericlamine
3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methylpropan-1-ol
CHEMBL2106462
112922-55-1
(+-)-3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methyl-1-propanol.
ves82d23ib ,
cericlamine [inn]
unii-ves82d23ib
(+-)-3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methyl-1-propanol
(+/-)-3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methyl-1-propanol
SCHEMBL114233
FWYRGHMKHZXXQX-UHFFFAOYSA-N
Q25101232
DTXSID00869558
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]